Bioventus Inc. (BVS)
NASDAQ: BVS · IEX Real-Time Price · USD
7.17
+0.10 (1.41%)
At close: Jul 19, 2024, 4:00 PM
7.19
+0.02 (0.28%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $457.64 million as of July 22, 2024. Its market cap has increased by 107.36% in one year.
Market Cap
457.64M
Enterprise Value
823.71M
1-Year Change
107.36%
Ranking
Category
Stock Price
$7.17
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $457.64M, a decrease of -35.86%. That is a compound annual growth rate of -12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 570.80M | 37.54% |
| Dec 29, 2023 | 415.00M | 104.53% |
| Dec 30, 2022 | 202.90M | -81.39% |
| Dec 31, 2021 | 1.09B | 52.78% |
| Feb 11, 2021 | 713.47M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enhabit | 475.98M |
| Theravance Biopharma | 465.42M |
| Anavex Life Sciences | 463.84M |
| MaxCyte | 459.99M |
| EyePoint Pharmaceuticals | 458.34M |
| Voyager Therapeutics | 455.27M |
| Pacific Biosciences of California | 452.11M |
| Absci | 448.94M |